Michael B. Cross
Corporate Officer/Principal bei SATELLOS BIOSCIENCE INC.
Ursprung des Netzwerks ersten Grades von Michael B. Cross
| Einheit | Art der Einheit | Industrie | |
|---|---|---|---|
| Public Company | Pharmaceuticals: Major | 16 | |
14
| Subsidiary | Pharmaceuticals: Major | 14 |
| Public Company | Medical/Nursing Services | 12 | |
Aegera Therapeutics, Inc.
 Aegera Therapeutics, Inc. BiotechnologyHealth Technology Aegera Therapeutics is a clinical stage biotechnology company focused on developing targeted therapeutics to address major unmet medical needs. Aegera has three programs in clinical development, two for oncology and one for neuropathic pain. Aegera is also dedicated to identifying novel development candidates based upon its core technologies and internal expertise and experience in rapidly moving lead candidates through preclinical development and into clinical trials.
11
| Subsidiary | Biotechnology | 11 |
ARTMS, Inc.
 ARTMS, Inc. BiotechnologyHealth Technology ARTMS, Inc. operates as biotechnology company, which develops novel technology and products. The company was founded by Michael Cross and is headquartered in Burnaby, Canada.
9
| Subsidiary | Biotechnology | 9 |
Trillium Therapeutics, Inc. /Old/
 Trillium Therapeutics, Inc. /Old/ Miscellaneous Commercial ServicesCommercial Services Trillium Therapeutics Inc. (TTI), is a biopharmaceutical company specializing in the development of innovative therapies for the treatment of immune-mediated disorders. The Company's therapeutic approaches are aimed at restoring balance to the immune system in conditions associated with aberrant or harmful immune responses, such as autoimmune disease, inflammatory disorders, and cancer. TTI's objective is to create a broad and innovative pipeline of proprietary biologic product opportunities, as part of its overall strategy of building and solidifying its reputation as a premier R & D company. The company's business model is to identify therapeutic candidates that have shown promise in animal models and to rapidly advance these into clinical testing. TTI is concentrating its efforts on preclinical and early clinical drug development, with the primary objective of demonstrating safety and proof-of-principle in man. The company has chosen to establish development partnerships for some of its projects at a preclinical stage, and anticipates advancing several others into clinical development on its own. TTI has five scientific programs at various stages of preclinical testing. Two of its programs focus on the immunoregulatory protein CD200 and its receptor, a third targets the activating Fc receptor Fc RIIa (CD32a) and the final two involve the use of a growth factor in the prevention of necrotizing enterocolitis and the treatment of interstitial cystitis.
6
| Extinct | Miscellaneous Commercial Services | 6 |
AdipoGenix, Inc.
 AdipoGenix, Inc. Pharmaceuticals: MajorHealth Technology AdipoGenix, Inc. develops molecular pharmaceutical products. It offers small molecule pharmaceuticals to treat obesity and its co-morbidities. The firm’s technology includes AdipoBASE, AdipoSCREEN, AdipoPATH and AdipoTARGET. The company was founded by Gerri Waloga, Barbara E. Corkey, Stephen R. Farmer, James A. Hamilton, James L. Kirkland, H. Jeff Leighton and Paul F. Pilch in 1997 and is headquartered in Boston, MA.
6
| Subsidiary | Pharmaceuticals: Major | 6 |
Praxim SA
 Praxim SA Medical SpecialtiesHealth Technology Praxim SA manufactures and sells orthopedic surgical instruments. It specializes in minimal invasive products for knee arthroscopy. The company was founded by Stéphane Lavallée in 1995 and is headquartered in La Tronche, France.
5
| Subsidiary | Medical Specialties | 5 |
Unternehmensgrafik - zweiten Grades
Beziehungen zu mehreren Unternehmen
Unternehmensverbindungen über das persönliche Netzwerk von Michael B. Cross
| Unternehmen | Sektor | Verknüpfte Personen | Hauptposition |
|---|---|---|---|
| APTOSE BIOSCIENCES INC. | Pharmaceuticals: Major | Director/Board Member Director of Finance/CFO Chief Administrative Officer Director/Board Member Chief Tech/Sci/R&D Officer | |
| TRILLIUM THERAPEUTICS | Biotechnology | Director/Board Member Director/Board Member Chief Executive Officer Director of Finance/CFO | |
| McGill University | College/University | Masters Business Admin Undergraduate Degree Undergraduate Degree Undergraduate Degree | |
| University of Western Ontario | College/University | Corporate Officer/Principal Masters Business Admin Undergraduate Degree Masters Business Admin | |
OMNIlife science, Inc.
 OMNIlife science, Inc. Medical SpecialtiesHealth Technology OMNIlife science, Inc. manufactures orthopedic, prosthetic and other related products. The firm products are used in hip and knee replacement, joint pain and robotic surgery. The company was founded by Edward J. Cheal and George B. Cipolletti in 1999 and is headquartered in Raynham, MA. | Medical Specialties | Director/Board Member Corporate Officer/Principal Director/Board Member | |
| SKYE BIOSCIENCE, INC. | Pharmaceuticals: Major | Chairman Chief Executive Officer Corporate Officer/Principal | |
| McMaster University | College/University | Masters Business Admin Undergraduate Degree Doctorate Degree | |
| RANGE IMPACT, INC. | Biotechnology | Chief Executive Officer Director/Board Member Director of Finance/CFO | |
Emerald Health Bioceuticals, Inc.
 Emerald Health Bioceuticals, Inc. BiotechnologyHealth Technology Emerald Health Bioceuticals, Inc. engages in the provision of research and development of cannabis-free nutritional supplements that support the body’s endocannabinoid system (ECS). Its products include Endo Omega, Endo OmegaVegan, Endo Immune, Endo Sleep, Endo Bliss, Endo Calm, Endo Inflame, and Endo Brain. The company was founded on March 27, 2015 and is headquartered in San Diego, CA. | Biotechnology | Chairman Chairman President | |
| Boston University | College/University | Corporate Officer/Principal Corporate Officer/Principal Corporate Officer/Principal | |
Emerald Health Pharmaceuticals, Inc.
 Emerald Health Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Emerald Health Pharmaceuticals, Inc. engages in the development of medicines based on cannabinoid science. It focuses on discovering, developing, and commercializing proprietary cannabinoid-derived medicines. The company is headquartered in San Diego, CA. | Pharmaceuticals: Major | President Chairman Director/Board Member | |
OMNI Orthopaedics, Inc.
 OMNI Orthopaedics, Inc. Medical SpecialtiesHealth Technology OMNI Orthopaedics, Inc. designs, manufactures, and distributes orthopedic implants. The company was founded by David L. Lasalle, George B. Cipoletti and Edward J. Cheal on December 22, 2008 and is headquartered in Taunton, MA. | Medical Specialties | Director/Board Member Director/Board Member Director/Board Member | |
| University of Pennsylvania | College/University | Corporate Officer/Principal Masters Business Admin Doctorate Degree | |
| INOVIO PHARMACEUTICALS, INC. | Pharmaceuticals: Major | Chairman General Counsel Director of Finance/CFO | |
| LPBP INC | Financial Conglomerates | Director/Board Member Director/Board Member | |
| Harvard Business School | College/University | Masters Business Admin Masters Business Admin | |
| University of British Columbia | College/University | Doctorate Degree Undergraduate Degree | |
Hybritech, Inc.
 Hybritech, Inc. Miscellaneous Commercial ServicesCommercial Services Hybritech, Inc. provides prostate diagnostic testing services. The company is headquartered in San Diego, CA. | Miscellaneous Commercial Services | Sales & Marketing Corporate Officer/Principal | |
| ARCH THERAPEUTICS, INC. | Medical Distributors | Chairman Director/Board Member | |
Triumvira Immunologics USA, Inc.
 Triumvira Immunologics USA, Inc. Miscellaneous Commercial ServicesCommercial Services Triumvira Immunologics USA, Inc. develops and manufactures novel T cell therapies for cancer. The company is based in Austin, TX and has subsidiaries in Canada. Paul Lammers has been the CEO of the company since 2018. | Miscellaneous Commercial Services | Director/Board Member Director/Board Member | |
| Stem Cell Network | Corporate Officer/Principal Chairman | ||
| ATS CORPORATION | Industrial Machinery | Director/Board Member Director/Board Member | |
| EMERALD HEALTH THERAPEUTICS | Agricultural Commodities/Milling | Chief Executive Officer Director/Board Member | |
Emerald Health Sciences, Inc.
 Emerald Health Sciences, Inc. Pharmaceuticals: MajorHealth Technology Emerald Health Sciences, Inc. develops cannabinoid pharmaceutical drugs. It targets botanicals including medical & recreational and nutraceutical segments. The company was founded on July 31 2007is headquartered in Victoria, Canada. | Pharmaceuticals: Major | Chief Executive Officer Director/Board Member | |
| University of Ottawa | College/University | Undergraduate Degree Corporate Officer/Principal | |
Alethia Biotherapeutics, Inc.
 Alethia Biotherapeutics, Inc. Pharmaceuticals: MajorHealth Technology Alethia Biotherapeutics, Inc. discovers and develops therapeutic mAbs against highly-disease tissue specific novel clinically-relevant targets. The firm focuses on bone loss in acute disorders, invasive carcinomas and on cancer-associated epithelial-to-mesenchymal transition. The company was founded in 2002 by Mario Filion and Yves Cornellier and is headquartered in Montreal, Canada. | Pharmaceuticals: Major | Chairman Director/Board Member | |
| TELESTA THERAPEUTICS INC | Pharmaceuticals: Other | Chief Executive Officer Director/Board Member | |
GeneChem Management, Inc.
 GeneChem Management, Inc. Investment ManagersFinance GeneChem Management Inc (GeneChem) is an independent venture capital firm founded in 1997. The firm is headquartered in Montréal. | Investment Managers | Private Equity Investor Private Equity Investor | |
Centre For Commercialization of Cancer Immunotherapy
 Centre For Commercialization of Cancer Immunotherapy Centre For Commercialization of Cancer Immunotherapy provides solution for the development, translation, and commercialization of cancer immunotherapy and regenerative medicine. It offers clinical research unit, contract research organization, and innovation and commercialization unit services. The company was founded by Lambert Busque, Denis-Claude Roy and is headquartered in Montréal, Canada. | Chairman Director/Board Member | ||
AgeChem Financial, Inc.
 AgeChem Financial, Inc. Financial ConglomeratesFinance AgeChem Financial, Inc. engages in the provision of investment services, It seeks to invest in companies developing therapeutics targeting age-related diseases. The company was founded in 2006 and is headquartered in Montreal, Canada. | Financial Conglomerates | Director/Board Member Director/Board Member | |
The Centre for Drug Research & Development
 The Centre for Drug Research & Development Miscellaneous Commercial ServicesCommercial Services Center for Drug Research & Development operates as a drug development and commercialization company. The firm provides the specialized expertise and infrastructure to identify, validate and advance promising discoveries, and transform them into commercially viable investment opportunities for the private sector and ultimately into new therapies for patients. The company was founded in 2007 and is headquartered in Vancouver, Canada. | Miscellaneous Commercial Services | Chief Executive Officer Director of Finance/CFO | |
Verio Therapeutics, Inc.
 Verio Therapeutics, Inc. BiotechnologyHealth Technology Part of Fate Therapeutics, Inc., Verio Therapeutics, Inc. is a Canadian pharmaceutical company that manufactures products for activating endogenous stem cells. The company is based in Ottawa, Canada. Verio Therapeutics was acquired by Fate Therapeutics, Inc. on April 08, 2010. The company was founded by Frank Gleeson, Michael Rudnicki. | Biotechnology | Founder Founder | |
| Simon Fraser University | College/University | Undergraduate Degree Corporate Officer/Principal | |
| The University of Waterloo | College/University | Graduate Degree Graduate Degree | |
Tutogen Medical, Inc.
 Tutogen Medical, Inc. Medical SpecialtiesHealth Technology Tutogen Medical, Inc. manufactures sterile biological implant products made from human and animal tissue. Tutogen utilizes its Tutoplast Process® of tissue preservation and viral inactivation to manufacture and deliver sterile bio-implants used in spinal/trauma, urology, dental, ophthalmology and general surgery procedures. The Company''s Tutoplast® products are sold and distributed worldwide by Zimmer Spine and Zimmer Dental, subsidiaries of Zimmer Holdings, Inc. the Mentor Corporation, IOP, Inc. and through independent distributors and subsidiaries in the U.S. and other international markets. Tutogen Medical is located in West Paterson, NJ. | Medical Specialties | Chief Tech/Sci/R&D Officer Chief Executive Officer | |
| BRISTOL-MYERS SQUIBB COMPANY | Pharmaceuticals: Major | Corporate Officer/Principal Corporate Officer/Principal | |
Ottawa Hospital Research Institute
 Ottawa Hospital Research Institute Hospital/Nursing ManagementHealth Services The Ottawa Hospital Research Institute is based in Ottawa, CA. The Canadian company provides world-class care with compassionate people. | Hospital/Nursing Management | Chairman Corporate Officer/Principal | |
| PROMIS NEUROSCIENCES, INC. | Biotechnology | Director of Finance/CFO Director of Finance/CFO | |
| Ottawa Life Sciences Council | Chairman Director/Board Member | ||
American Chemical Society
 American Chemical Society Miscellaneous Commercial ServicesCommercial Services American Chemical Society engages as a scientific society which supports scientific inquiry in the field of chemistry. The company was founded in 1876 and is headquartered in Washington, DC. | Miscellaneous Commercial Services | Corporate Officer/Principal Corporate Officer/Principal | |
Enztec Ltd.
 Enztec Ltd. Medical SpecialtiesHealth Technology Enztec Ltd. provides orthopedic medical devices. It specialises in creating orthopedic instrument solutions for implant companies and orthopedic surgeons worldwide. The firm offers bespoke design, manufacturing services and contract manufacturing. The company was founded by Paul Morrison and James Burn in 1992 and is headquartered in Christchurch, New Zealand. | Medical Specialties | Director/Board Member Director/Board Member | |
Fight Against Cancer Innovation Trust
 Fight Against Cancer Innovation Trust Investment ManagersFinance Fight Against Cancer Innovation Trust is a venture capital firm founded in 2014. The firm is headquartered in Toronto, Canada. | Investment Managers | Director/Board Member Private Equity Investor | |
National Institutes of Health
 National Institutes of Health General GovernmentGovernment National Institutes Of Health conducts & supports peer-reviewed medical research and science. The firm's scientists & researchers investigate on different ways to prevent diseases as well as the causes, treatments and cures for common and rare diseases. The company was founded in 1887 and is headquartered in Bethesda, MD. | General Government | Corporate Officer/Principal Corporate Officer/Principal |
Statistik
International
| Kanada | 32 |
| Vereinigte Staaten | 17 |
| Israel | 2 |
| Irland | 2 |
| Neuseeland | 2 |
Sektoral
| Health Technology | 22 |
| Consumer Services | 11 |
| Commercial Services | 6 |
| Finance | 6 |
| Distribution Services | 2 |
Operativ
| Director/Board Member | 355 |
| Corporate Officer/Principal | 151 |
| Chairman | 72 |
| Independent Dir/Board Member | 66 |
| President | 55 |
Am stärksten vernetzte Beziehungen
| Insiders | |
|---|---|
| Steve Hochberg | 47 |
| Franklin Berger | 41 |
| Anthony Maida | 32 |
| Louis P. Lacasse | 26 |
| Avtar Dhillon | 25 |
| Andreas Wicki | 21 |
| Michael Berendt | 20 |
| Richard McKilligan | 19 |
| Kenneth Edward Newport | 19 |
| Joe Regan | 17 |
| Michael G. Moore | 16 |
| William Albert Etherington | 16 |
| Karimah Es Sabar | 16 |
| Robert W. Luba | 15 |
| Brian Bloom | 15 |
- Börse
- Insiders
- Michael B. Cross
- Unternehmensverbindungen
